These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3143616)

  • 21. Key features for the identification of 250 hospital isolates of Pseudomonas aeruginosa, with observation on their in vitro susceptibility to 10 antibiotics.
    Nabbut NH; Faydi Y
    J Med Liban; 1974; 27(2):229-35. PubMed ID: 4138455
    [No Abstract]   [Full Text] [Related]  

  • 22. Study of Pseudomonas aeruginosa in relation to pyocine typing drug sensitivity and epidemiology.
    Mohanty SK; Bhuyan BK; Nathsarma KC; Nanda BK
    Indian J Pathol Microbiol; 1982 Jan; 25(1):45-9. PubMed ID: 6809612
    [No Abstract]   [Full Text] [Related]  

  • 23. [Trend of resistant Pseudomonas aeruginosa from field of clinical laboratory medicine].
    Oguri T; Misawa S; Igari J
    Nihon Rinsho; 1991 Oct; 49(10):2367-72. PubMed ID: 1749094
    [No Abstract]   [Full Text] [Related]  

  • 24. [Phenotypic relations with regard to pyocin sensitivity, of 191 strains of Pseudomonas aeruginosa isolated in a hospital environment].
    Santini G; Targa S; Basaglia M; Marchetti G; Crovatto M
    Boll Ist Sieroter Milan; 1983 Jul; 62(3):242-6. PubMed ID: 6416270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyocine types and antibiotic sensitivity of hospital strains of Pseudomonas aeruginosa.
    Shrinivas ; Bhatia VN; Ramachandran K
    Indian J Pathol Bacteriol; 1971 Jan; 14(1):24-31. PubMed ID: 5004283
    [No Abstract]   [Full Text] [Related]  

  • 26. Pseudomonas aeruginosa: antibiotic susceptibility and genotypic characterization of strains isolated in the intensive care unit.
    Bertrand X; Thouverez M; Patry C; Balvay P; Talon D
    Clin Microbiol Infect; 2001 Dec; 7(12):706-8. PubMed ID: 11843917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L-form of Pseudomonas aeruginosa. 2. Antibiotic sensitivity of L-forms and their parent forms.
    Yamamoto A; Homma JY
    Jpn J Exp Med; 1978 Aug; 48(4):355-62. PubMed ID: 101702
    [No Abstract]   [Full Text] [Related]  

  • 28. Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients.
    Nazik H; Ongen B; Erturan Z; Salcioğlu M
    Jpn J Infect Dis; 2007 May; 60(2-3):82-6. PubMed ID: 17515637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pseudomonas aeruginosa and Escherichia coli: reliability of antibiotic resistance results obtained by manual tests and automated and semi-automated equipment].
    Moretti MV; Bianchi P; Grossholz G; Moretti A; Pasticci MB; Frongillo RF
    Nuovi Ann Ig Microbiol; 1985; 36(6):453-64. PubMed ID: 3939640
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of the in vitro activity of new beta-lactams and aminoglycosides against clinical isolates of Pseudomonas aeruginosa.
    Patzer J; Gieburowska R; Dzierzanowska D
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Oct; 253(1):110-20. PubMed ID: 6817544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of azithromycin as an antipseudomonal agent.
    Mahapatra A; Mahapatra A; Padhi S; Mahapatro S; Ghosh SK
    Indian J Pathol Microbiol; 2006 Oct; 49(4):634-5. PubMed ID: 17183885
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients.
    Adachi JA; Perego C; Graviss L; Dvorak T; Hachem R; Chemaly RF; Raad II
    Am J Infect Control; 2009 Aug; 37(6):442-6. PubMed ID: 19118923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of multiple Pseudomonas aeruginosa strains with different characteristics in clinical specimens; combined results from serotyping, drug susceptibility and enzyme production].
    Nakasone I; Kusano N; Hokama S
    Rinsho Byori; 1995 Nov; 43(11):1135-9. PubMed ID: 8551677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pseudomonas aeruginosa isolated in immunocompromised patients: antimicrobial resistance, serotyping, and molecular typing].
    Kalai S; Achour W; Abdeladhim A; Bejaoui M; Ben Hassen A
    Med Mal Infect; 2005 Nov; 35(11):530-5. PubMed ID: 16309870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of Pseudomonas aeruginosa infection in hospitals. 1. Pyocine typing of Ps. aeruginosa.
    Tagg JR; Mushin R
    Med J Aust; 1971 Apr; 1(16):847-52. PubMed ID: 4995944
    [No Abstract]   [Full Text] [Related]  

  • 36. The incidence of serotype O12 and multiresistance amongst Pseudomonas aeruginosa clinical isolates.
    Patzer J; Dzierzanowska D
    J Antimicrob Chemother; 1994 Jul; 34(1):165-70. PubMed ID: 7961204
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antibiotic associations on acting Pseudomonas aeruginosa].
    Duval J; Mathieu-Saint-Laurent P; Soussy CL
    Pathol Biol (Paris); 1971; 19(11):637-48. PubMed ID: 4997792
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pseudomonas aeruginosa 012 identified in Catalonian hospitals].
    Tirado M; Roy C; Reig R; López-Yeste ML; Chaves J
    Enferm Infecc Microbiol Clin; 1993; 11(7):400-1. PubMed ID: 8399485
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of antimicrobial sensitivity patterns as markers of Pseudomonas aeruginosa cross-infection at a cystic fibrosis clinic.
    Williams T
    Br J Biomed Sci; 1997 Sep; 54(3):181-5. PubMed ID: 9499595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antibiotic sensitivity of different antigenic variants of Pseudomonas aeruginosa isolated in a hospital].
    Sheina EP; Arutcheva AA
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Apr; (4):30-3. PubMed ID: 6408856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.